Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kallikrein-related peptidase 3 (KLK3), also known as prostate-specific antigen (PSA), is a serine protease enzyme secreted by the prostate gland. It plays a crucial role in semen liquefaction and is widely used as a biomarker for prostate cancer and other prostatic diseases. KLK3 is also implicated in various biological processes, including cell growth regulation, apoptosis, and immune response modulation, and is an attractive therapeutic target.
Inhibition of KLK3 enzymatic activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kallikrein-related Peptidase 3 (PSA).